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Abstract
Background: The purpose of the present study was to compare the serum levels of IL6 and CA125
in women with and without endometriosis. They were also compared in mild, moderate and severe
cases.
Methods: In this case-control study, CA125 and IL6 levels in 76 women with laparoscopic proven
endometriosis were compared with 76 women without evidence of endometriosis. Sensitivity, speci-
ficity, positive (PPV) and negative (NPV) predictive values were then calculated for each test.
Results: Both groups did not show significant difference in their age, BMI, ESR and gravidity.
Mean serum levels of IL-6 and CA125 were significantly higher in the case group (30.4±6.43 vs
13.9±3.17 Pg/ml and 62.6±10.69 vs 16.6±1.79 IU/ml respectively). Considering a cutoff point of 30
Pg/ml for IL-6, sensitivity, specifically, PPV and NPV value of 21.1%, 66.6%, 86.8% and 23.37%
were obtained, respectively. Considering a cutoff point of 35 IU/ml for CA125, sensitivity, specifi-
cally, PPV and NPV were 44.76%, 94.73%, 89.47% and 63.15%, respectively. Area under the ROC
curve was 0.69 for CA125 and 0.54 for IL6, which showed a low value for these tests.
Conclusion: Although CA125 and IL-6 were higher than normal controls in endometriosis, area
under the ROC curve, did not show significant any diagnostic value for these tests.
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Introduction
Endometriosis is a progressive disease
which consists of implantation of a combi-
nation of endometrial tissue including both
stromal and glands outside the uterine cavi-
ty and may cause pelvic pain, severe intra-
peritoneal adhesions and sub-fertility. It is
more common in women who complain of
chronic pelvic pain, dysmenorrhea and in-
fertility (1,2). Standard diagnostic method
for endometriosis is laparoscopic evalua-
tion and histologic confirmation of find-
ings. Laparoscopy is an invasive procedure
(1) and needs hospitalization and anesthe-
sia. Ultrasound and MRI can help for the
diagnosis of endometriosis too. Lack of
non-invasive diagnostic methods leads to
late diagnosis of endometriosis (3). Finding
a noninvasive and simple method of diag-
nosis for evaluation of the women who are
suspicious for endometriosis is always un-
der serious concern. CA125 is a kind of cell
surface antigen which is high in most cases
of endometriosis, and has been proposed as
a screening method for this disease. How-
ever, a meta-analysis on 22 studies, report-
ed a very low diagnostic value for this test.
(1,2).
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Serial measurement of CA125 may help for
following up the patients after treatment
(2). The cytokines including IL-6 have
been proposed in the pathogenesis of en-
dometriosis (4). IL-6 which is a multifunc-
tional cytokine has been shown in a very
high level in the peritoneal fluid of endo-
metriotic women (5). Surgery for endome-
triosis may reduce the level of serum IL-6;
it may decrease after GnRH agonist therapy
(6). Interleukin–1 is a responsible cytokine
in inflammatory and immunologic respons-
es and is secreted from monocytes, activat-
ed macrophages, B and T lymphocytes and
NK cells. It has been found in peritoneal
fluid of endometriotic women and may
cause activation of endometriotic tissue
through releasing of angiogenic factors in-
cluding IL6. In a study in 2002, IL6 was
found higher in serum of endometriotic
women. In this study (4), area under the
ROC curve of 87% was calculated for se-
rum IL-6. Other studies (3,6-9) showed
similar results. In contrast, some studies
could not show diagnostic or prognostic
value for serum IL6 in endometriotic wom-
en (5,8-12). The purpose of the present
study was to compare the serum level of
IL6 and CA125 in the women with and
without endometriosis. Morover, they were
compared in minimal to mild and moderate
to severe cases.
Methods
Data
This case-control study was performed on
women who underwent laparoscopy for
their gynecologic problems including tubal
ligation, abnormal uterine bleeding, infertil-
ity, pelvic pain, and … in Rasool-e-Akram
Teaching Hospital in Tehran, Iran, between
March 2010 and March 2013. Serum levels
of IL-6 and CA125 were measured in all
women with and without the diagnosis of
endometriosis and were compared between
these two groups. Endometriosis was de-
fined as minimal to mild if it was found on
the surface of peritoneum and ovaries with-
out deep and severe adhesions (1). Endo-
metriosis was defined as moderate to severe
if it was invasive, with large endometrio-
mas and deep and extensive adhesion ac-
cording to AFS (American Fertility Society
classification) scoring system (1). Inclusion
criteria included women of reproductive
age who were the candidate for laparoscop-
ic evaluation of their gynecologic prob-
lems. Exclusion criteria included women
with the diagnosis of acute pelvic inflam-
matory disease (PID) and vaginal dis-
charge, women with any known history of
inflammatory disorder or high erythrocyte
sedimentation rate (ESR), neoplastic disor-
ders, history of fever during past seven
days, any medication for endometriosis
during the last 3 months, laparoscopic find-
ings of other pathologies except endometri-
osis in laparoscopy and elevated ESR. Lap-
aroscopy was performed by two expert lap-
aroscopic surgeons who made the diagnosis
and staging of endometriosis. In this study
considering α = 0.05 and β= 0.1, OR=3 a
sample size of 76 women in each group
was calculated. Seventy six women with
confirmed diagnosis of endometriosis in
laparoscopy were compared with women
who had normal laparoscopic findings.
Matching was performed according to the
patients’ age.  Three mLit of peripheral
blood was collected in eligible women be-
fore laparoscopy and the serum IL-6 (ELI-
SA, Bender Med, Canada) and CA125
(ELEXIS, Roche, Germany) were meas-
ured and compared between the groups.
Statistical Analysis
The obtained data were analyzed using
SPSS 16. Quantitative data was calculated
as mean ± standard deviation and qualita-
tive data was calculated as numbers and
percentages. Univariate analysis and chi-
square test were utilized for comparing
quantitative and qualitative data, respec-
tively. . Receiver operative characteristics
(ROC) curve was used for determination of
diagnostic value. P-value of less than 0.05
was considered significant. For maximum
diagnostic value (sensitivity of 100% and
specificity of 100%) and corresponding
confidence intervals (CI), the area under
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the ROC curve is 1; and in the minimum
diagnostic value, that the diagnosis is total-
ly by chance, the area under the curve is
0.5.
Results
A total of 152 women were evaluated by
laparoscopy, including 76 women in endo-
metriosis or case group, and 76 women in
the control group. Mean age, gravidity,
body mass index (BMI), and ESR did not
show significant difference between the
two groups (Table 1). Table 2 shows chief
complaints of women in the each group; it
shows significant difference (p= 0.001).
Mean serum levels of IL-6 and CA125
were higher in the case group (table 3). Se-
rum level of IL-6 was not higher in mini-
mal to mild endometriosis than control
group; however, it was higher in moderate
to severe endometriosis (Tables 4 and 5).
Serum level of CA125 was higher in both
minimal to mild and moderate to severe
endometriosis than control group (tables 4
and 5). For a cutoff point of 35 IU/ml for
CA125, sensitivity, specificity, PPV and
NPV were 44.76%, 94.73%, 89.47% and
63.15%, respectively (Figure 1). For a
threshold of 30 Pg/ml for IL-6, sensitivity,
specificity, PPV and NPV were 21.1%,
66.6%, 86.8% and 23.37%, respectively
(Fig. 2 and Table 6). Figure 1 and table 6
Table 1 . Demographic characteristics of the women in each group
Characteristics Control group (n = 76) Case group(n = 76) p
Age (year) M±SD 29.5 ±  6.8 29.5 ± 6.8 1
BMI M±SD 24.3±4.2 22.88±4.02 0.06
ESR M±SD 10.7±3.6 10.2±3.5 0.403
Gravidity
Single 6 (7.9%) 20 (26.3%)
0.071
0 32 (42.1%) 29 (38.2%)
1 15 (19.7%) 13 (17.1%)
2 13 (17.1%) 9 (11.8%)
≥3 10 (13.2%) 5 (6.6%)
Table 2. Chief complaints of women in each group
Control group (n= 76) Case group (n= 76)
Abdominal pain  n ( % ) 22 (28.9%) 45 (59.2%)
Dysmenorrhea  n ( % ) 2 (2.6%) 11 (14.5%)
Infertility   n ( % ) 19 (22.4%) 35 (46.1%)
Abnormal uterine bleeding   n ( % ) 3 (3.9%) 9 (11.8%)
TL   n ( % ) 5 (6.6%) 0 (0%)
recurrent abortion  n ( % ) 3 (3.9%) 0 (0%)
Table 3. Mean serum level of IL-6 and CA125 in each group
Control group (n= 76) Case group (n= 76) p
IL-6 (Pg/ml)
M±SD
13.98±3.17 30.42±6.43 0.048
CA125 (Iu/ml)
M±SD
16.65±1.79 62.65±10.69 0.0001
Table 4. Mean serum level of IL-6 and CA125 in minimal to mild endometriosis and control groups
Control group Minimal to mild group p
IL-6 (Pg/ml)
M±SD
13.98±3.17 16.97±3.11 0.34
CA125 (IU/ml)
M±SD
16.65±1.79 56.29±7.45 0.013
Table 5. Mean serum level of IL-6 and CA125 in moderate to severe endometriosis and control groups
Control group moderate to severe p
IL-6 (Pg/ml)
M±SD
13.98±3.17 32.12±6.74 0.034
CA125 (Iu/ml)
M±SD
16.65±1.79 100.16±22.99 0.022
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show the ROC curve of diagnostic value of
CA125 for diagnosis of endometriosis with
confidence intervals. The area under the
curve is 0.69, and does not show significant
value. Figure 2 shows the ROC curve of
value of the IL-6 for prediction of endome-
triosis. Area under the curve is 0.54 and
shows no significant diagnostic value.
Discussion
In the present study both CA125 and IL-6
levels were higher in patients with endome-
triosis; however, CA125 level was high in
both minimal to mild and mild to moderate
endometriosis, and IL-6 level was higher
just in moderate to severe cases. ROC
curve showed low diagnostic value for IL-
Table 6. Diagnostic accuracy parameters of CA125, and IL-6. (n=152)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPP
(%)
Accuracy
(%)
CA125
CI 95%
44.76
(33.3 – 56.5)
94.73
(87.06 – 98.54)
89.47
(75.1 – 97.01)
63.15
(53.6 – 71.9)
69.7
(61.7 – 76.9)
IL-6
CI 95%
21.1
(12.5 – 31.9)
66.6
(54.1 – 76.29)
38.09
(23.5 – 54.3)
45.4
(35.9 – 55.2)
43.4
(35.4 – 51.6)
Fig. 1. ROC curve for CA125
Fig. 2. ROC curve for IL-6
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6; therefore it cannot be considered as a
suitable diagnostic or prognostic test. IL-6
which is a multifunctional cytokine, has
been shown in the peritoneal fluid of en-
dometriotic women in a very high level (5).
Surgery for endometriosis may reduce the
level of serum IL-6, and it may decrease
after GnRh agonist therapy (6). In a pro-
spective study on 91 cases of endometriosis
(4) who had been undergone laparoscopy,
serum and peritoneal level of IL and other
cytokines were evaluated. The researchers
showed elevated serum level of IL-6 in en-
dometriosis. Another studies (3, 8) showed
similar results. Serum level of CA125 was
higher in moderate to severe cases of en-
dometriosis compared with minimal to mild
cases (3). A case-control study on 68 en-
dometriotic women and 70 normal women,
reported higher serum level of IL-6 in en-
dometriotic women which were in accord-
ance with some other studies (6,7). Addi-
tionally, Martinez et al. (13) in a case-
control study on 47 case of endometriosis
and 72 normal cases, showed elevated level
of IL-6 in endometriosis. In contrast, some
other studies have questioned the value of
serum IL-6 for diagnosis of endometriosis
with this hypothesis that IL-6 was secreted
by both ectopic and utopic endometrial
stromal cells (5,9). on the other hand, some
studies could not show higher level of IL-6
in endometriosis than normal women
(11,12); they proposed that IL-6 cannot add
more information than CA125 for the man-
agement of endometriosis (10). Another
study on 13 women could not show signifi-
cant difference between serum and perito-
neal fluid IL-6 level in women with deep
endometriosis and superficial endometrio-
sis (10,12)
Conclusion
Considering controversies between our
results and also within previous studies, it
is suggested that more studies to be per-
formed on cases with various severities of
endometriosis before proposing a definitive
conclusion.
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